Lysosomal Storage Disease Therapeutic (REGENXBIO)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLysosomal Storage Disease Therapeutic (REGENXBIO)
Drug Alias NameLysosomal Storage Disease Therapeutic (RegenX)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLysosomal Storage DiseasesEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRegenxbio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegenxbio Inc
Active IndicationsN/A
Inactive IndicationsLysosomal Storage DiseasesEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A